| Code | Description | Total Paid |
| U0004 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r |
$3.02M |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
$454K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
$424K |
| 84443 |
Thyroid stimulating hormone (TSH) |
$259K |
| P9603 |
Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated miles actually travelled |
$240K |
| 80053 |
Comprehensive metabolic panel |
$209K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
$208K |
| 80061 |
Lipid panel |
$155K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
$104K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
$85K |